The Nystatin and Triamcinolone Aceto, cataloged under National Stock Number 6505-01-242-8353, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Goldline Laboratories, Inc. Dba Goldline Laboratories. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 4 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 9 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-242-8353 |
| Primary Part Number | NDC00182-1799-51 |
| Item Name | Nystatin and Triamcinolone Aceto |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Goldline Laboratories, Inc. Dba Goldline Laboratories |
| Status | ACTIVE |
| Therapeutic Equivalent | MYOGEN II CREAM BY GOLDLINE LABS. |
| Primary Container Content Quantity | 15.000 GRAMS G |
| Administration | TOPICAL |
| Primary Container Type | TUBE, COLLAPSIBLE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| NDC00182-1799-51 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| 50341 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| MYCOGEN II CREAM | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00168-0081-15 PRIMARY | Fougera Pharmaceuticals Inc. Dba Pharmaderm Div Fougera/savage Labs/pharmaderm (USA) |
NSN 6505-01-242-8353 is a Nystatin and Triamcinolone Aceto, manufactured by Goldline Laboratories, Inc. Dba Goldline Laboratories, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-242-8353 has 4 cross-referenced part numbers: NDC00182-1799-51 (Goldline Laboratories, Inc. Dba Goldline Laboratories), 50341 (Goldline Laboratories, Inc. Dba Goldline Laboratories), MYCOGEN II CREAM (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00168-0081-15 (Fougera Pharmaceuticals Inc. Dba Pharmaderm Div Fougera/savage Labs/pharmaderm).
There are 9 known substitutes for 6505-01-242-8353: 2810-00-118-2344, 5330-00-236-1413, 2530-00-488-8316 and 6 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00182-1799-51: Therapeutic Equivalent: MYOGEN II CREAM BY GOLDLINE LABS.; Primary Container Content Quantity: 15.000 GRAMS G; Administration: TOPICAL; Primary Container Type: TUBE, COLLAPSIBLE. 4 total characteristics are documented in the Federal Logistics Information System.